These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 19490828

  • 1. Antidiabetic medications and weight gain: implications for the practicing physician.
    McFarlane SI.
    Curr Diab Rep; 2009 Jun; 9(3):249-54. PubMed ID: 19490828
    [Abstract] [Full Text] [Related]

  • 2. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
    Purnell JQ, Weyer C.
    Treat Endocrinol; 2003 Jun; 2(1):33-47. PubMed ID: 15871553
    [Abstract] [Full Text] [Related]

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Jun; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 4. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC, Teoh H.
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [Abstract] [Full Text] [Related]

  • 5. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight.
    Bonora E.
    Int J Clin Pract Suppl; 2007 Aug; (154):19-28. PubMed ID: 17593274
    [Abstract] [Full Text] [Related]

  • 6. Effect of thiazolidinediones on body weight in patients with diabetes mellitus.
    Fonseca V.
    Am J Med; 2003 Dec 08; 115 Suppl 8A():42S-48S. PubMed ID: 14678865
    [Abstract] [Full Text] [Related]

  • 7. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Hermansen K, Mortensen LS.
    Drug Saf; 2007 Dec 08; 30(12):1127-42. PubMed ID: 18035865
    [Abstract] [Full Text] [Related]

  • 8. [How to minimize weight gain associated with insulin treatment].
    Philippe J.
    Rev Med Suisse; 2010 Jun 09; 6(252):1199-200, 1202-4. PubMed ID: 20614755
    [Abstract] [Full Text] [Related]

  • 9. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Jun 09; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 10. Diabetes medications and body weight.
    Mitri J, Hamdy O.
    Expert Opin Drug Saf; 2009 Sep 09; 8(5):573-84. PubMed ID: 19538102
    [Abstract] [Full Text] [Related]

  • 11. Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?
    Brown A, Guess N, Dornhorst A, Taheri S, Frost G.
    Diabetes Obes Metab; 2017 Dec 09; 19(12):1655-1668. PubMed ID: 28509408
    [Abstract] [Full Text] [Related]

  • 12. Thiazolidinediones, insulin resistance and obesity: Finding a balance.
    Wilding J.
    Int J Clin Pract; 2006 Oct 09; 60(10):1272-80. PubMed ID: 16981971
    [Abstract] [Full Text] [Related]

  • 13. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Oct 09; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 14. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K, Davies M.
    Diabetes Obes Metab; 2007 May 09; 9(3):209-17. PubMed ID: 17391147
    [Abstract] [Full Text] [Related]

  • 15. Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.
    Medici V, McClave SA, Miller KR.
    Curr Gastroenterol Rep; 2016 Jan 09; 18(1):2. PubMed ID: 26700070
    [Abstract] [Full Text] [Related]

  • 16. A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.
    Barnett A, Allsworth J, Jameson K, Mann R.
    Curr Med Res Opin; 2007 Jul 09; 23(7):1493-507. PubMed ID: 17559747
    [Abstract] [Full Text] [Related]

  • 17. Use of insulin and weight gain: optimizing diabetes nutrition therapy.
    Daly A.
    J Am Diet Assoc; 2007 Aug 09; 107(8):1386-93. PubMed ID: 17659906
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
    Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B, Diabetes Outcome Progression Trial (ADOPT) Study Group.
    Diabetes Care; 2010 Jan 09; 33(1):177-83. PubMed ID: 19808911
    [Abstract] [Full Text] [Related]

  • 19. Weight management in type 2 diabetes: current and emerging approaches to treatment.
    Van Gaal L, Scheen A.
    Diabetes Care; 2015 Jun 09; 38(6):1161-72. PubMed ID: 25998297
    [Abstract] [Full Text] [Related]

  • 20. Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study.
    Rigalleau V, Delafaye C, Baillet L, Vergnot V, Brunou P, Gatta B, Gin H.
    Diabetes Metab; 1999 Sep 09; 25(4):321-8. PubMed ID: 10566121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.